-
-
-
-
-
-
-
Needham & Company Downgrades Hyperion Therapeutics (HPTX) to Hold Amid Takeover Deal
-
-
-
-
-
-
-
Hyperion Therapeutics (HPTX) Settles with Clal Biotech, Yeda Research; Enters Agreement on DiaPep277 Phase 3
-
-
-
-
-
-
-
Hyperion Therapeutics (HPTX) Bullish Stance Reiterated at Needham & Company Amid Strong Q1 Ravicti Sales
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

